Subsidiary of Hob Biotech Group Corp., Ltd (688656.SH) obtained 2 medical device registration certificates.

16:03 18/03/2026

Hao Ou Bo (688656.SH) announced that its wholly-owned subsidiary, Hunan Hao Ou Bo Biomedical Medicine Co., Ltd., has recently obtained two medical device registration certificates approved and issued by the Hunan Provincial Drug Administration, involving products: "Anti-Cytoplasmic tRNA Synthetase (PL-12) Antibody Test Kit (Chemiluminescent Microparticle Immunoassay)" and "Anti-Threonyl tRNA Synthetase (PL-7) Antibody Test Kit (Chemiluminescent Microparticle Immunoassay)".

Hob Biotech Group Corp., Ltd (688656.SH) announced that its wholly-owned subsidiary, Hunan Hob Biotech Group Corp., Ltd Biomedicine Co., Ltd., has recently obtained 2 medical device registration certificates approved and issued by the Hunan Provincial Drug Administration, involving products: "Anti-threonyl-tRNA synthetase (PL-12) antibody test kit (magnetic chemiluminescence method)" and "Anti-seryl-tRNA synthetase (PL-7) antibody test kit (magnetic chemiluminescence method)".

HUNLICAR GROUP (03638) spent HK$50,000 to repurchase 5,000 shares on March 18th.

PEIPORT HOLD (02885) announces that it is expecting a net profit attributable to shareholders of approximately HK$3 million to HK$4 million for the fiscal year 2025, turning a loss into a profit compared to the previous year.

On March 18th, Le Saunda (00738) spent 511,600 Hong Kong dollars to repurchase 1,574,000 shares.

HUNLICAR GROUP (03638) spent HK$50,000 to repurchase 5,000 shares on March 18th.

On March 18th, Le Saunda (00738) spent 511,600 Hong Kong dollars to repurchase 1,574,000 shares.